Elanco Animal Health (ELAN) Depreciation & Amortization (CF) (2017 - 2026)

Elanco Animal Health has reported Depreciation & Amortization (CF) for 10 years, with the latest figure at $172.0 million in Q1 2026.

• Quarterly Depreciation & Amortization (CF) rose 6.83% year-over-year to $172.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $691.0 million (up 5.18% YoY) and the FY2025 annual result came in at $680.0 million, up 2.72% from the prior year.
• Depreciation & Amortization (CF) eased to $172.0 million in Q1 2026 per ELAN's latest filing, from $174.0 million in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $177.0 million in Q2 2023 and troughed at $161.0 million in Q1 2025.
• A 5-year average of $170.0 million and a median of $171.0 million in 2022 frame the typical range for Depreciation & Amortization (CF).
• The sharpest annual moves came in 2022 and 2026: Depreciation & Amortization (CF) retreated 12.87% in 2022, then rose 6.83% in 2026.
• Over 5 years, Depreciation & Amortization (CF) stood at $168.0 million in 2022, then grew by 1.79% to $171.0 million in 2023, then decreased by 4.09% to $164.0 million in 2024, then increased by 6.1% to $174.0 million in 2025, then slipped by 1.15% to $172.0 million in 2026.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $172.0 million, $174.0 million, and $176.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.